Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | MCB | UVSP |
|---|---|---|
| Price | $87.05 | $40.89 |
| Change today | ▼ 1.89% | ▼ 1.16% |
| Market cap | $1.08B | $1.13B |
| Return, 3 months | -10.7% | -6.2% |
| Return, year to date | +15.0% | +27.1% |
| Return, 1 year | +16.6% | +40.5% |
| P/E (TTM) | 11.1 | 11.8 |
| P/B | 1.1 | 1.2 |
| P/E percentile vs own 5y | 58th | 86th |
| Dividend yield | 0.86% | 2.18% |
| Revenue growth (YoY, latest qtr) | +21.9% | +4.1% |
| Net profit growth (YoY) | +2.4% | +14.9% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | 24.8% | 29.0% |
| Return on equity | 10.2% | 10.5% |
| Analyst target vs. price | +20.6% | +14.9% |
| Analyst buy share | 50% | 0% |
| RSI (14) | 39 | 38 |
| 30-day volatility | 17.0% | 12.2% |
| Max drawdown, 1 year | -18.7% | -9.1% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
